World news, news around town, tech update 3
Ad
Wednesday, 7 June 2017
AstraZeneca sells migraine drug for up to $302 million
LONDON (Reuters) - AstraZeneca continued its program of divesting old medicines on Wednesday with the sale for up to $302 million of migraine drug Zomig to Germany's Grunenthal.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment